Furthermore, GRIN2B dysfunction has been implicated in motor and cognitive deficits in α-synuclein-induced mouse models, and treatment with a GRIN2B inhibitor has been shown to rescue motor impairments in PD (10). Here, GRIN2B is linked to Parkinson disease.